Sign in
4

Changes in Ownership

Niagen Bioscience, Inc. Filed Acc 0001415889-16-004790

Director sold 5,063 shares at $1.26 ($6,379)

From the SEC's structured data for this filing

Trades in this filing

Fried Robert N · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2016-01-29 Sale : show line 1 in the form −5,063 $1.26 $6,379 155,937 D
Open-market sales · 5,063 sh · avg $1.26 · $6,379
Loading xslF345X03/form4-02162016_010242.xml…